dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorMillennium Initiative for Collaborative Research On Bacterial Resistance (MICROB-R)
dc.contributorUniversidad Andres Bello
dc.contributorUniversidad del Desarrollo
dc.contributorPontificia Universidad Católica de Chile
dc.date.accessioned2021-06-25T10:55:03Z
dc.date.accessioned2022-12-19T22:29:00Z
dc.date.available2021-06-25T10:55:03Z
dc.date.available2022-12-19T22:29:00Z
dc.date.created2021-06-25T10:55:03Z
dc.date.issued2021-05-01
dc.identifierPreventive Veterinary Medicine, v. 190.
dc.identifier0167-5877
dc.identifierhttp://hdl.handle.net/11449/207432
dc.identifier10.1016/j.prevetmed.2021.105316
dc.identifier2-s2.0-85102389846
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5388029
dc.description.abstractFaecal carriage of extended-spectrum cephalosporin-resistant Escherichia coli (ESC-R E. coli) in dogs has been reported worldwide and can reduce the effectiveness of treatments against bacterial infections. However, the drivers that influence faecal carriage of ESC-R E. coli in dogs are poorly understood. The aims of this study were to estimate the prevalence of ESC-R E. coli among dogs prior to their admission to a veterinary teaching hospital and to identify risk factors associated with the faecal carriage of ESC-R E. coli. Rectal swabs (n = 130) were collected from dogs and screened for ESC-R E. coli using MacConkey agar supplemented with cefotaxime (2 μg/mL). E. coli species was confirmed by MALDI-TOF and screening of extended-spectrum beta-lactamase (ESBL) genes was conducted by multiplex PCR. Questionnaires were completed by each dog's owner to test several human and dog characteristics associated with ESC-R E. coli. The prevalence of faecal carriage of ESC-R E. coli was 9.2 % and 67 % of ESC-R E. coli isolates harboured ESBL genes including CTX-M alone or in combination with TEM. All ESC-R E. coli isolates were resistant to ceftriaxone, cefpodoxime, and cefotaxime and were susceptible to cefoxitin and carbapenems. The likelihood of carrying ESC-R E. coli was 15 times higher (OR = 14.41 [95 % CI: 1.80−38.02], p < 0.01) if the dog was treated with antibiotics 3–12 months prior to sampling and 8 times higher (OR = 7.96 [95 % CI: 2.96−92.07], p < 0.01) if the dog had direct contact with livestock, but 15 times lower (OR = 0.07 [95 % CI: 0.01−0.32], p < 0.01) if the dog was dewormed during the previous year. Our findings confirm the faecal carriage of ESC-R E. coli in subclinical dogs and call for further investigation regarding the impact of deworming on antibiotic-resistant bacteria in companion animals.
dc.languageeng
dc.relationPreventive Veterinary Medicine
dc.sourceScopus
dc.subjectAntimicrobial resistance
dc.subjectCompanion animals
dc.subjectDeworming
dc.subjectE. coli
dc.subjectExtended-spectrum beta-lactamase
dc.subjectLatin America
dc.titleRisk factors associated with faecal carriage of extended-spectrum cephalosporin-resistant Escherichia coli among dogs in Southeast Brazil
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución